Drs A.W. Boots

Vasarmidi, E., Worrell, J. C., Mahmutovic Persson, I., Yaqub, N., Miadlikowska, E., Barnig, C., Boots, A., Reynaert, N. L., & Cuevas Ocaña, S. (2025). Insights into interstitial lung disease pathogenesis. Breathe, 21(2), Article 240261. https://doi.org/10.1183/20734735.0261-2024

Hintzen, K. F. H., Blanchet, L., Smolinska, A., Boumans, M.-L., Stobberingh, E. E., Dallinga, J. W., Lubbers, T., van Schooten, F.-J., & Boots, A. W. (2024). Volatile organic compounds in headspace characterize isolated bacterial strains independent of growth medium or antibiotic sensitivity. PLOS ONE, 19(1), Article e0297086. https://doi.org/10.1371/journal.pone.0297086

Ocana, S. C., El-Merhie, N., Kuipers, M. E., Lehmann, M., Enes, S. R., Voss, C., Dean, L. S. N., Loxham, M., Boots, A. W., Cloonan, S. M., Greene, C. M., Heijink, I. H., Joannes, A., Mailleux, A. A., Mansouri, N., Reynaert, N. L., Van der Does, A. M., Wagner, D. E., & Ubags, N. (2023). ERS International Congress 2022: highlights from the Basic and Translational Science Assembly. ERJ Open Research, 9(2), Article 00561-2022. https://doi.org/10.1183/23120541.00561-2022

Veith, C., Schneider, M. A., Maas, L., van der Vliet, A., van Schooten, F. J., Kreuter, M., Meister, M., Boots, A. W., & Kahn, N. (2023). Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine? Antioxidants, 12(2), Article 443. https://doi.org/10.3390/antiox12020443

Mathioudakis, A. G., Osadnik, C., Boots, A. W., Bradicich, M., Bartel, S., Gloeckl, R., & Cruz, J. (2022). Inspiring stories: the impact that being part of ERS activities can have on a professional career. Breathe, 18(1), Article 210217. https://doi.org/10.1183/20734735.0217-2021

Plantier, L., Smolinska, A., Fijten, R., Flamant, M., Dallinga, J., Mercadier, J. J., Pachen, D., d'Ortho, M. P., van Schooten, F. J., Crestani, B., & Boots, A. W. (2022). The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study. Respiratory Research, 23(1), Article 12. https://doi.org/10.1186/s12931-021-01923-5

Ophelders, D. R. M. G., Boots, A. W., Hütten, M. C., Al-Nasiry, S., Jellema, R. K., Spiller, O. B., van Schooten, F. J., Smolinska, A., & Wolfs, T. G. A. M. (2021). Screening of Chorioamnionitis Using Volatile Organic Compound Detection in Exhaled Breath: A Pre-clinical Proof of Concept Study. Frontiers in pediatrics, 9, Article 617906. https://doi.org/10.3389/fped.2021.617906

Veith, C., Hristova, M., Danyal, K., Habibovic, A., Dustin, C. M., McDonough, J. E., Vanaudenaerde, B. M., Kreuter, M., Schneider, M. A., Kahn, N., van Schooten, F. J., Boots, A. W., & van der Vliet, A. (2021). Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYN. American Journal of Physiology-Lung Cellular and Molecular Physiology, 320(3), L356-L367. https://doi.org/10.1152/ajplung.00444.2019

Pauwels, C. G. G. M., Hintzen, K. F. H., Talhout, R., Cremers, H. W. J. M., Pennings, J. L. A., Smolinska, A., Opperhuizen, A., Van Schooten, F. J., & Boots, A. W. (2021). Smoking regular and low-nicotine cigarettes results in comparable levels of volatile organic compounds in blood and exhaled breath. Journal of Breath Research, 15(1), Article 016010. https://doi.org/10.1088/1752-7163/abbf38

Lukassen, S., Chua, R. L., Trefzer, T., Kahn, N. C., Schneider, M. A., Muley, T., Winter, H., Meister, M., Veith, C., Boots, A. W., Hennig, B. P., Kreuter, M., Conrad, C., & Eils, R. (2020). SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. The Embo Journal, 39(10), Article 105114. https://doi.org/10.15252/embj.20105114